Bayer (BAYRY)
(Delayed Data from OTC)
$8.03 USD
-0.09 (-1.11%)
Updated Sep 25, 2024 03:59 PM ET
2-Buy of 5 2
B Value C Growth F Momentum C VGM
Bayer Aktiengesellschaft (BAYRY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.50 | $8.50 | $8.50 | 4.68% |
Price Target
Only one analyst offered a short-term price target of $8.50 for Bayer Aktiengesellschaft. This represents an increase of 4.68% from the last closing price of $8.12.
Analyst Price Targets (1 )
Broker Rating
Bayer Aktiengesellschaft currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 3.08 a month ago based on 12 recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 12 | 12 | 11 | 10 | 10 |
Sell | 0 | 0 | 1 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.08 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | Not Identified | Not Identified | Hold | Hold |
6/15/2024 | Not Identified | Not Identified | Hold | Hold |
6/14/2024 | Berenberg Bank | Sebastian Bray | Hold | Hold |
5/30/2024 | Goldman Sachs | James Quigley | Not Available | Hold |
3/7/2024 | Not Identified | Not Identified | Not Available | Hold |
2/29/2024 | Not Identified | Not Identified | Not Available | Hold |
2/20/2024 | Not Identified | Not Identified | Moderate Sell | Hold |
1/30/2024 | Not Identified | Not Identified | Strong Buy | Hold |
12/4/2023 | UBS | Michael Leuchten | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 12 |
Average Target Price | $8.50 |
LT Growth Rate | NA |
Industry | Large Cap Pharmaceuticals |
Industry Rank by ABR | 42 of 253 |
Current Quarter EPS Est: | 0.17 |
BAYRY FAQs
Bayer Aktiengesellschaft (BAYRY) currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for Bayer Aktiengesellschaft (BAYRY) is $8.50. The current on short-term price targets is based on 2 reports.
The forecasts for Bayer Aktiengesellschaft (BAYRY) range from a low of $8.5 to a high of $8.5. The average price target represents a increase of $4.68 from the last closing price of $8.12.
The current UPSIDE for Bayer Aktiengesellschaft (BAYRY) is 4.68%
Only one analyst offered a short-term price target of $8.50 for Bayer Aktiengesellschaft. This represents an increase of 4.68% from the last closing price of $8.12.